Rosetta Genomics Chairman and CEO Isaac Bentwich this week described as "misleading and inaccurate" an article in an Israeli newspaper reporting that his company was planning a June 2006 initial public offering on the Nasdaq, but fell short of denying the story outright.

He also declined to reaffirm statements he made to RNAi News late last year about a potential IPO planned for 2007, raising questions as to whether the company has altered its plans or prerequisites to float its shares in the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.